JPH0350758B2 - - Google Patents
Info
- Publication number
- JPH0350758B2 JPH0350758B2 JP57216053A JP21605382A JPH0350758B2 JP H0350758 B2 JPH0350758 B2 JP H0350758B2 JP 57216053 A JP57216053 A JP 57216053A JP 21605382 A JP21605382 A JP 21605382A JP H0350758 B2 JPH0350758 B2 JP H0350758B2
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- activated carbon
- magnesium salt
- phosphorylated
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005909 Kieselgur Substances 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000004927 clay Substances 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- -1 ascorbic acid phosphate ester magnesium salt Chemical class 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 229960005070 ascorbic acid Drugs 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 150000000996 L-ascorbic acids Chemical class 0.000 description 10
- 235000010323 ascorbic acid Nutrition 0.000 description 10
- 239000011668 ascorbic acid Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000012264 purified product Substances 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- NGPNWUWGVIIIDG-LEJBHHMKSA-L magnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] phosphate Chemical class [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP([O-])([O-])=O NGPNWUWGVIIIDG-LEJBHHMKSA-L 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- POXJXWXPDYFTJM-ZAFYKAAXSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] dihydrogen phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP(O)(O)=O POXJXWXPDYFTJM-ZAFYKAAXSA-N 0.000 description 1
- RTNNQCWNWGBXAC-JDYVBSGKSA-J [Mg+2].[O-]P([O-])(=O)OP(=O)([O-])[O-].O=C1C(O)=C(O)[C@H](O1)[C@@H](O)CO.[Mg+2] Chemical compound [Mg+2].[O-]P([O-])(=O)OP(=O)([O-])[O-].O=C1C(O)=C(O)[C@H](O1)[C@@H](O)CO.[Mg+2] RTNNQCWNWGBXAC-JDYVBSGKSA-J 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Description
本発明は燐酸化アスコルビン酸又はその塩類の新
規な精製方法に関するものである。
従来、アスコルビン酸は、その有する優れた生
理作用により、医薬品、食品、化粧品その他の各
種工業分野に使用されているが、本来、熱や光に
弱く、さらにその水溶液は安定性が悪いため、分
解や着色をし易いなどの欠点がある。これを改善
する目的で、各種誘導体がこれまで合成されてい
る。その中でも、アスコルビン酸の燐酸化エステ
ルやその塩類は、生体内で容易にアスコルビン酸
に転換する特徴を有すると共に、現在提供されて
いる他の誘導体に較べ、水を含有する湿性製品で
の安定性がもつとも優れていると云われている。
しかしながら、これらの燐酸化アスコルビン酸
化合物であつても、例えばアスコルビン酸燐酸エ
ステルマグネシウム塩を用いる工業製品の場合、
水が存在する系では、経時的に徐々に着色が進行
する傾向がある。こゝにおけるアスコルビン酸燐
酸エステルマグネシウム塩自体を分析もしくは定
量してもその含有量の減少は認められない。従つ
て、おそらくは、アスコルビン酸を出発原料とし
て合成するアスコルビン酸燐酸エステルマグネシ
ウム塩を製造する過程において、副反応が生じ、
これに起因して微量の不純物が混在するものと考
えられる。
本発明者は、このような不純物を除き、着色の
ない精製された燐酸化アスコルビン酸化合物を収
率よく、経済的に得るため、鋭意研究した結果、
ついに目的とする本発明を完成するに到つたので
ある。
すなわち、本発明は燐酸化アスコルビン酸又は
その塩類の精製方法に関するもので、その特徴と
するところは、燐酸化アスコルビン酸又はその塩
類を水に溶解させ、活性炭、ケイソウ土、酸性白
土等から選択される一種又は二種以上の担体に吸
着させて脱色処理を行い、得られる液低級アル
コール類、ケトン類あるいはテトラヒドロフラン
等から選択されるいずれか一種又は二種以上の有
機溶媒を添加せしめて生成物を沈澱させ、これを
過した後、前記有機溶媒により洗浄し、乾燥す
ることを特徴とするものである。
次に、本発明に係る新規精製方法について、ア
スコルビン酸燐酸エステルマグネシウム塩を例に
して詳述すると、粗製アスコルビン酸燐酸エステ
ルマグネシウム塩を水に溶解させて0.1〜10%
(重量%)を得、カラム法又はバツチ法を用いて
活性炭、ケイソウ土、酸性白土等の担体は好まし
く活性炭に吸着させて(水で溶出することによ
り)脱色処理を行い、微量の着色物質及び不純物
を除去する。この際、必要により担体微粉末を除
去するため、ミルポアフイルター(ミルポア社)
等で過処理を行う。得られるカラム通過液もし
くはバツチ処理過液等の液に対し、メタノー
ル、エタノール、イソプロパノール、ブタノー
ル、イソブタノール等の低級アルコール類、アセ
トン等のケトン類、テトラヒドロフランなどから
選択される一種又は二種以上の有機溶媒を20〜55
%(容量%)になる様に添加せしめて室温で10時
間以上又は40℃で1時間以上、もしくは5℃で4
時間以上放置し、アスコルビン酸燐酸エステルマ
グネシウム塩を沈澱させる。これを過せしめ、
上記有機溶媒の少なくとも一種好ましくはメタノ
ール、エタノール、アセトン等を用いて洗浄し、
次いで適宜の方法で乾燥させて脱水処理し、白色
粉末状の精製されたアスコルビン酸燐酸エステル
マグネシウム塩を得る。
上記以外の燐酸化アスコルビン酸過物について
もほヾ同様の方法を用いたが、目的とすべき精製
品は得られた。
本発明において重要なことは、上記の精製過程
における有機溶媒の濃度が20〜55容量%望ましく
は30〜45容量%の範囲に維持されることである。
55重量%を越える場合、アスコルビン酸燐酸エス
テルマグネシウム塩と共に不純物も沈澱し、目的
とする精製効果が得られにくい。20容量%未満で
は収率が著しく低下し、工業製品として実用的で
ない。これらの有機溶媒の濃度は、目的とする燐
酸化アスコルビン酸化合物の種類によつては、増
減されてもよい。さらに必要なことは燐酸化アス
コルビン酸と活性炭の担体(吸着材)の重量比が
1対5〜1対0.1の範囲(好ましくは1対1〜1
対0.2)に入る様にすることである。1対5より
担体が多いと回収率が著しく低下し、1対0.1よ
り担体が少ないと精製効果が出にくい。
次に、本発明の精製方法の実施例を示す。
実施例 1
L−アスコルビン酸−2−リン酸エステルマグ
ネシウム塩(未精製品)10.0gを精製水500mlに
溶解する。この溶液に活性炭粉末10.0gを添加し
室温にて30分間撹拌し3時間放置し活性炭に吸着
させ脱色処理する。吸引過により過し、精製
水100mlずつで2回洗浄し、液と洗液を併せる。
この液を0.22ミクロンのミリポアフイルターを用
いて過する。液にメタノール550mlを撹拌し
つゝ加え、室温にて一晩放置する。生じたL−ア
スコルビン酸−2−リン酸エステルマグネシウム
塩の白色沈澱を過しアセトンで洗浄脱水する。
次いで風乾し、シリカゲルデシケーター中に一週
間放置して目的とする精製品7.5gを得た。(収率
75%)
実施例 2
L−アスコルビン酸−2−リン酸エステルマグ
ネシウム塩(未精製品)20.0gを精製水500mlに
溶解する。この溶液にケイソウ土(和光)10.0g
及び活性炭粉末10.0gを添加し、室温にて30分間
撹拌する。1時間放置しケイソウ土と活性炭に吸
着させ脱色処理した後吸引過する。精製水100
mlづつで2回洗浄する。液と洗液を合せ、紙
上の担体をこの液を0.22ミクロンのミリポアフイ
ルターを用いて過する。液にアセトン400ml
を撹拌しつゝ添加した後、40℃にて1時間保ち、
沈澱を熱成させる。次いでこれを過した後、ア
セトンにて洗浄脱水し減圧乾燥して目的とする白
色の精製品16.0gを得た。(収率80.0%)
実施例 3
L−アスコルビン酸−2−リン酸エステルマグ
ネシウム塩(未精製品)20.0gを精製水400mlに
溶解する。これを活性炭カラム(和光クロマト用
活性炭50メツシユ10.0gを水に分散し、径5cmの
ガラスカラムに充填)に注入し通過せしめて活性
炭に吸着させ脱色処理する。精製水により溶出さ
せ、カラム通過液の全量が1000mlになつたところ
で溶出を終了する。0.22ミクロンのミリポアフイ
ルターを用いてカラム通過液を過し、活性炭の
微粒子の除去する。液を撹拌しつゝエタノール
600mlを加え一晩放置してL−アスコルビン酸−
2−リン酸エステルマグネシウム塩の沈澱を生じ
せしめる。次いでこれを過した後、エタノール
(1級)により洗浄し、減圧乾燥して目的とする
精製品14.7gを得た。(収率73.5%)
実施例 4
L−アスコルビン酸−2−リン酸エステルマグ
ネシウム塩(未精製品)30.0gを精製水500mlに
溶解する。これを活性炭カラム(和光クロマト用
活性炭50メチシユ20gを水に分散し、内径5cmの
ガラスカラムに充填)に注入し通過せしめて活性
炭に吸着させ脱色処理する。精製水により溶出さ
せ、カラム通過液の全量が1000mlになつたところ
で溶出を終了する。0.22ミクロンのミリポアフイ
ルターを用いてカラム通過液を過し、活性炭の
微粒子を除去する。液を撹拌しつゝ1級アセト
ン650mlを加え5℃−4時間放置してL−アスコ
ルビン酸−2−リン酸1級アセトンマグネシウム
塩を沈澱させる。次にこれで過した後、アセト
ン洗浄し、撹拌しつゝ窒素気流下で乾燥して目的
とする精製品23.8gを得た。(収率79.3%)
上記の如くして得られた精製燐酸化アスコルビ
ン酸又はその塩類を各種水溶液に添加せしめるこ
とにより、着色のない安定な燐酸化アスコルビン
酸化合物を含有した水溶液が提供されるものであ
る。そして、更なる安定化の向上を図るため、ク
エン酸、酒石酸、リンゴ酸等の有機酸を一種又は
二種添加してもよい。このような有機酸は燐酸化
アスコルビン酸化合物0.1〜5%(重量%)の水
溶液100部に対し、0.1〜3部が適量である。
本発明の精製された燐酸化アスコルビン酸化合
物と精製未処理の燐酸化アスコルビン酸化合物に
ついて、その水溶液の安定性試験を行つた結果を
下記表−1(高温安定性)及び表−2(経時安定
性)を以つて示す。尚、表−1及び表−2におけ
る試料はNaOH(1−N)とHCl(1−N)でPH
8.0に調整したものである。
着色の測定:試料の360nmにおける吸光度(セ
ル長1cm)により着色の度合を測定した。デー
タは吸光度で示した。
アスコルビン酸リン酸エステルマグネシウム塩含
有量(残存率%):アスコルビン酸リン酸エステ
ルマグネシウム塩の含有量を鉄塩比色法により
測定し、試料作成時(無処理)を100とした時
の統対値(%)で示した。
The present invention relates to a novel method for purifying phosphorylated ascorbic acid or its salts. Conventionally, ascorbic acid has been used in pharmaceuticals, foods, cosmetics, and various other industrial fields due to its excellent physiological effects. It has disadvantages such as easy coloring. Various derivatives have been synthesized for the purpose of improving this. Among these, phosphorylated esters of ascorbic acid and their salts have the characteristic of being easily converted into ascorbic acid in vivo, and are more stable in wet products containing water than other derivatives currently available. It is said that it is also excellent. However, even with these phosphorylated ascorbic acid compounds, for example, in the case of industrial products using ascorbic acid phosphate ester magnesium salt,
In systems where water is present, coloration tends to progress gradually over time. Even when the ascorbic acid phosphate ester magnesium salt itself is analyzed or quantified, no decrease in its content is found. Therefore, side reactions probably occur during the process of producing ascorbic acid phosphate magnesium salt, which is synthesized using ascorbic acid as a starting material.
It is thought that this is the reason why a small amount of impurities are mixed. As a result of intensive research, the present inventor has conducted extensive research in order to remove such impurities and obtain a purified phosphorylated ascorbic acid compound without coloration in a high yield and economically.
At last, the objective of the present invention was completed. That is, the present invention relates to a method for purifying phosphorylated ascorbic acid or its salts, which is characterized in that phosphorylated ascorbic acid or its salts are dissolved in water, and a method for purifying phosphorylated ascorbic acid or its salts is carried out using activated carbon, diatomaceous earth, acid clay, etc. The resulting liquid is adsorbed onto one or more types of carriers and decolorized, and the resulting liquid is added with one or more organic solvents selected from lower alcohols, ketones, tetrahydrofuran, etc. to form the product. The method is characterized in that it is precipitated, filtered, washed with the organic solvent, and dried. Next, the novel purification method according to the present invention will be explained in detail using ascorbic acid phosphate magnesium salt as an example.
(wt%), and a carrier such as activated carbon, diatomaceous earth, or acid clay is preferably adsorbed onto activated carbon (by elution with water) using a column method or a batch method, and then decolorized (by elution with water) to remove trace amounts of colored substances and Remove impurities. At this time, in order to remove carrier fine powder if necessary, use a Milpore filter (Millepore Co., Ltd.).
etc. to perform overprocessing. One or more types selected from lower alcohols such as methanol, ethanol, isopropanol, butanol, isobutanol, ketones such as acetone, tetrahydrofuran, etc. organic solvent 20-55
% (volume %) at room temperature for more than 10 hours, at 40°C for more than 1 hour, or at 5°C for more than 4 hours.
Leave to stand for more than an hour to precipitate ascorbic acid phosphate magnesium salt. Let this pass,
Washing with at least one of the above organic solvents, preferably methanol, ethanol, acetone, etc.,
Next, it is dried and dehydrated by an appropriate method to obtain purified magnesium salt of ascorbic acid phosphate ester in the form of a white powder. The same method was used for phosphorylated ascorbic acid peroxides other than those mentioned above, but the desired purified products were obtained. What is important in the present invention is that the concentration of the organic solvent in the above purification process is maintained in the range of 20 to 55% by volume, preferably 30 to 45% by volume.
If it exceeds 55% by weight, impurities will precipitate together with the ascorbic acid phosphate magnesium salt, making it difficult to obtain the desired purification effect. If it is less than 20% by volume, the yield will drop significantly and it will not be practical as an industrial product. The concentration of these organic solvents may be increased or decreased depending on the type of phosphorylated ascorbic acid compound targeted. What is further required is that the weight ratio of phosphorylated ascorbic acid and activated carbon carrier (adsorbent) is in the range of 1:5 to 1:0.1 (preferably 1:1 to 1).
0.2). When the amount of carrier is more than 1:5, the recovery rate decreases significantly, and when the amount of carrier is less than 1:0.1, it is difficult to obtain a purification effect. Next, examples of the purification method of the present invention will be shown. Example 1 10.0 g of L-ascorbic acid-2-phosphate magnesium salt (unpurified product) is dissolved in 500 ml of purified water. 10.0 g of activated carbon powder was added to this solution, stirred at room temperature for 30 minutes, and left to stand for 3 hours to be adsorbed onto the activated carbon and decolorized. Filter by suction, wash twice with 100 ml each of purified water, and combine the liquid and washing liquid.
This solution is filtered using a 0.22 micron Millipore filter. Add 550 ml of methanol to the solution while stirring, and leave it at room temperature overnight. The resulting white precipitate of L-ascorbic acid-2-phosphate magnesium salt is filtered, washed with acetone, and dehydrated.
Next, it was air-dried and left in a silica gel desiccator for one week to obtain 7.5 g of the desired purified product. (yield
75%) Example 2 20.0 g of L-ascorbic acid-2-phosphate magnesium salt (unpurified product) is dissolved in 500 ml of purified water. Add 10.0g of diatomaceous earth (Wako) to this solution.
and 10.0 g of activated carbon powder, and stirred at room temperature for 30 minutes. The solution was left for 1 hour to be adsorbed onto diatomaceous earth and activated carbon, decolorized, and then filtered with suction. Purified water 100
Wash twice with ml each. The solution and washing solution are combined and the solution is filtered through a 0.22 micron Millipore filter over the carrier on paper. 400ml of acetone in the liquid
After adding with stirring, keep at 40℃ for 1 hour,
Heat the precipitate. After passing through this, the mixture was washed with acetone, dehydrated, and dried under reduced pressure to obtain 16.0 g of the desired white purified product. (Yield: 80.0%) Example 3 20.0 g of L-ascorbic acid-2-phosphate magnesium salt (unpurified product) is dissolved in 400 ml of purified water. This is injected into an activated carbon column (10.0 g of activated carbon for Wako chromatography dispersed in water and packed into a glass column with a diameter of 5 cm) and allowed to pass through, where it is adsorbed onto the activated carbon and decolorized. Elute with purified water, and end the elution when the total volume of the column-passing liquid reaches 1000 ml. Filter the column flow through a 0.22 micron Millipore filter to remove activated carbon particles. Add ethanol while stirring the liquid.
Add 600ml and leave it overnight to dissolve L-ascorbic acid.
2-Phosphate ester magnesium salt is precipitated. After passing through this, the residue was washed with ethanol (first grade) and dried under reduced pressure to obtain 14.7 g of the desired purified product. (Yield 73.5%) Example 4 30.0 g of L-ascorbic acid-2-phosphate magnesium salt (unpurified product) is dissolved in 500 ml of purified water. This is injected into an activated carbon column (20 g of activated carbon for Wako chromatography dispersed in water and packed into a glass column with an inner diameter of 5 cm) and allowed to pass through, where it is adsorbed onto the activated carbon and decolorized. Elute with purified water, and end the elution when the total volume of the column-passing liquid reaches 1000 ml. Filter the column flow through a 0.22 micron Millipore filter to remove activated carbon particles. While stirring the solution, 650 ml of primary acetone was added, and the mixture was allowed to stand at 5°C for 4 hours to precipitate the magnesium salt of primary acetone L-ascorbic acid-2-phosphate. Next, the mixture was filtered, washed with acetone, and dried under a nitrogen stream while stirring to obtain 23.8 g of the desired purified product. (Yield 79.3%) By adding the purified phosphorylated ascorbic acid or its salts obtained as described above to various aqueous solutions, an aqueous solution containing a stable phosphorylated ascorbic acid compound without coloration is provided. It is. In order to further improve stability, one or two organic acids such as citric acid, tartaric acid, and malic acid may be added. The appropriate amount of such an organic acid is 0.1 to 3 parts per 100 parts of an aqueous solution of 0.1 to 5% (wt%) phosphorylated ascorbic acid compound. The results of stability tests of aqueous solutions of the purified phosphorylated ascorbic acid compound and the unpurified phosphorylated ascorbic acid compound of the present invention are shown in Table 1 (high temperature stability) and Table 2 (temporal stability) below. gender). In addition, the samples in Tables 1 and 2 were pH-treated with NaOH (1-N) and HCl (1-N).
It has been adjusted to 8.0. Measurement of coloration: The degree of coloration was measured by the absorbance of the sample at 360 nm (cell length 1 cm). Data were expressed as absorbance. Ascorbic acid phosphate ester magnesium salt content (residual rate %): The content of ascorbic acid phosphate ester magnesium salt is measured by the iron salt colorimetric method, and is a unified value when the time of sample preparation (untreated) is set as 100. Shown as value (%).
【表】
未精製品ははじめからかなりの着色が認められ
るが100℃の処理により激しく着色し悪臭が生じ
ていた。これに反して精製品はほんのわずかしか
着色が認められず100℃−3時間の処理でも変臭
が起つていなかつた。
クエン酸の添加は精製品、未精製品においてか
なりの添加効果が認められるものの、これだけで
は変臭、着色を防止出来なかつた。又別の実験に
おいて、酒石酸、リンゴ酸等の有機酸においても
クエン酸と同様の効果があることが認められた。[Table] The unrefined product was considerably colored from the beginning, but the treatment at 100°C resulted in severe coloration and a foul odor. On the other hand, the purified product showed only a slight amount of coloring and did not develop any odor even after being treated at 100°C for 3 hours. Although the addition of citric acid has a considerable effect on purified and unrefined products, it alone was not able to prevent odor and coloration. In another experiment, it was found that organic acids such as tartaric acid and malic acid had the same effect as citric acid.
【表】
40℃、室温の経時試験においても精製品はほと
んど又はほんの少ししか着色せず、顕著な精製効
果が認められた。
しかしアスコルビン酸リン酸エステルマグネシ
ウム塩含有量はほとんど変化せず、着色の原因は
共存する小量の不純物によるものと推定される。
又、表−3に燐酸化アスコルビン酸化合物の精
製時での溶媒濃度等の影響を示す。[Table] Even in the aging test at 40°C and room temperature, the purified product was hardly or only slightly colored, and a remarkable purification effect was observed. However, the ascorbic acid phosphate magnesium salt content hardly changed, and it is presumed that the cause of the coloring was a small amount of coexisting impurities. Furthermore, Table 3 shows the influence of solvent concentration, etc. during purification of the phosphorylated ascorbic acid compound.
【表】
エタノール濃度は低いほど精製効果が高かつ
た。一般に55%(容量%)以下の溶媒濃度が精製
に有効であつた。別の実験において、メタノー
ル、イソプロパノール類の低級アルコール、アセ
トンなどのケトン類等にも同様の効果が認められ
た。但し溶媒濃度20%(容量%)未満では回収率
が低いため工業的には実用的ではなかつた。
本発明により精製される燐酸化アスコルビン酸
化合物を具体的に挙げると、L−アスコルビン酸
−3−リン酸エステル、L−アスコルビン酸−2
−リン酸エステルマグネシウム塩、同カルシウム
塩、同ナトリウム塩、L−アスコルビン酸ピロリ
ン酸マグネシウム塩その他各種の化合物等であ
る。
以上詳述した通り、本発明は燐酸化アスコルビ
ン酸又はその塩類の新規な精製方法に関するもの
であり、着色のない安定な各種燐酸化アスコルビ
ン酸化合物が好収率、高純度で提供される。本発
明により得られた精製燐酸化アスコルビン酸化合
物は、各種工業分野に適用され、特に化粧品にお
いては、化粧水等の水溶液で着色のない製品が有
利に得られるだけでなく、クリーム類、乳液類、
ゲル状物、粉体類等に使用でき、従来にない優れ
た品質特性と生理活性のあるアスコルビン酸化合
物が提供されるものである。[Table] The lower the ethanol concentration, the higher the purification effect. In general, solvent concentrations below 55% (volume %) were effective for purification. In other experiments, similar effects were observed with lower alcohols such as methanol and isopropanol, and ketones such as acetone. However, if the solvent concentration is less than 20% (volume %), the recovery rate will be low and it is not industrially practical. Specifically, the phosphorylated ascorbic acid compounds purified by the present invention include L-ascorbic acid-3-phosphate, L-ascorbic acid-2
-Phosphate ester magnesium salt, same calcium salt, same sodium salt, L-ascorbic acid pyrophosphate magnesium salt, and various other compounds. As detailed above, the present invention relates to a novel method for purifying phosphorylated ascorbic acid or its salts, and provides various stable phosphorylated ascorbic acid compounds without coloration in good yield and high purity. The purified phosphorylated ascorbic acid compound obtained by the present invention is applied to various industrial fields, and in particular, in cosmetics, it is useful not only for producing color-free products in aqueous solutions such as lotions, but also for creams, milky lotions, etc. ,
The present invention provides an ascorbic acid compound that can be used in gels, powders, etc., and has unprecedented quality characteristics and physiological activity.
Claims (1)
解させ、活性炭、ケイソウ土、酸性白土等から選
択される少なくとも一種類以上の担体に吸着させ
て脱色処理を行い、得られるロ液に低級アルコー
ル類、ケトン類あるいはテトラヒドロフラン等か
ら選択される少なくとも一種類以上の有機溶媒を
20〜55容量%濃度になる様に添加せしめて生成物
を沈澱させ、これをロ過した後、前記有機溶媒に
より洗浄し、乾燥することを特徴とする燐酸化ア
スコルビン酸又はその塩類の精製方法。1 Dissolve phosphorylated ascorbic acid or its salts in water and decolorize it by adsorbing it on at least one type of carrier selected from activated carbon, diatomaceous earth, acid clay, etc., and lower alcohols, At least one organic solvent selected from ketones, tetrahydrofuran, etc.
A method for purifying phosphorylated ascorbic acid or its salts, which comprises adding the product to a concentration of 20 to 55% by volume to precipitate the product, filtering it, washing it with the organic solvent, and drying it. .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21605382A JPS59106494A (en) | 1982-12-09 | 1982-12-09 | Purification of phosphorylated ascorbic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21605382A JPS59106494A (en) | 1982-12-09 | 1982-12-09 | Purification of phosphorylated ascorbic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59106494A JPS59106494A (en) | 1984-06-20 |
JPH0350758B2 true JPH0350758B2 (en) | 1991-08-02 |
Family
ID=16682540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21605382A Granted JPS59106494A (en) | 1982-12-09 | 1982-12-09 | Purification of phosphorylated ascorbic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59106494A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6296410A (en) * | 1985-10-22 | 1987-05-02 | Showa Denko Kk | Bathing agent |
US5516919A (en) * | 1994-04-28 | 1996-05-14 | Wako Pure Chemical Industries, Ltd. | Process for producing ascorbic acid derivative |
EP1059298B1 (en) * | 1999-06-07 | 2002-11-27 | F. Hoffmann-La Roche Ag | Process for purifying L-ascorbyl 2-monophosphate |
WO2001066552A1 (en) * | 2000-03-03 | 2001-09-13 | Akzo Nobel N.V. | Benzofuranone stabilization of phosphate esters |
JP2012140330A (en) * | 2010-12-28 | 2012-07-26 | Tosoh Corp | Method for purifying water soluble phosphoric ester |
-
1982
- 1982-12-09 JP JP21605382A patent/JPS59106494A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59106494A (en) | 1984-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1065196A1 (en) | Process of selectively separating and purifying eicosapentaenoic and docosahexaenoic acids or their esters | |
JP4594298B2 (en) | High purity fondaparinux sodium composition | |
US5124452A (en) | Process for producing d,1-5-methyltetrahydrofolic acid and its salts | |
JP2003535866A (en) | Method for purifying a composition comprising at least one internal dehydration product of a hydrogenated sugar | |
KR930007966A (en) | Method for preparing 2-0-α-D-glucopyranosyl-L-ascorbic acid high content | |
JPH0350758B2 (en) | ||
JP5295744B2 (en) | Method for producing theacinensin | |
JP2005263632A (en) | Method for producing a composition containing high-concentration chlorogenic acids | |
US3748358A (en) | Method of purification of n-acetyl-p-aminophenol | |
IT8320359A1 (en) | IMPROVED PROCEDURE FOR THE PURIFICATION OF TILOSTNA | |
CA2178369C (en) | Process for the purification and crystallisation of iopamidol | |
US5223500A (en) | Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate | |
JP3840672B2 (en) | Method for producing ascorbic acid derivative | |
KR950004899B1 (en) | Process for preparing moranoline derivatives | |
TW387886B (en) | Process for producing ascorbic acid derivative | |
CN108997379B (en) | Sulfur-containing bergenin derivative with antioxidant activity and synthesis method thereof | |
JP3143512B2 (en) | Melanin production inhibitor and method for producing the same | |
KR930001318B1 (en) | Decolorization and Purification Method of Polydextrose Using Activated Carbon and Ion Exchange Resin | |
US3883585A (en) | Process for purifying and stabilizing aqueous alkali metal salt solutions of sorbic acid | |
JPH03275629A (en) | Ginkgo extract and production thereof | |
BE1010651A3 (en) | Process for the purification of cefalexin. | |
US20020151431A1 (en) | Recovery method | |
US5783688A (en) | Purification of 3'-FDDU and resultant compositions | |
JPS62103096A (en) | Purification of l-ascorbic acid 2-phosphate | |
JPH03109343A (en) | Production of 2,3',4,5'-tetrahydroxystilbene |